AIkido Pharma (AIKI) Gets a Buy from H.C. Wainwright
12 November 2022 - 01:55AM
TipRanks
In a report released today, Vernon Bernardino from H.C. Wainwright
maintained a Buy rating on AIkido Pharma (AIKI - Research Report),
with a price target of $16.00. The company's shares opened today at
$4.30.Bernardino covers the Healthcare sector, focusing on stocks
such as Geron, Artelo Biosciences, and Cassava Sciences. According
to TipRanks, Bernardino has an average return of 19.4% and a 32.49%
success rate on recommended stocks. AIkido Pharma has an analyst
consensus of Moderate Buy, with a price target consensus of
$16.00.See Insiders’ Hot Stocks on TipRanks >> The company
has a one-year high of $13.90 and a one-year low of $4.14.
https://www.tipranks.com/news/blurbs/aikido-pharma-aiki-gets-a-buy-from-h-c-wainwright?utm_source=advfn.com&utm_medium=referral
Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
From May 2023 to Jun 2023
Alkido Pharma (NASDAQ:AIKI)
Historical Stock Chart
From Jun 2022 to Jun 2023
